More on HCWB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.46 |
|
|||
| Open | $2.42 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $2.52 | ||||
| Day Low | $2.41 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 19,844 | ||||
- Form 8-K HCW Biologics Inc. For: Sep 09
- HCW Biologics signs distribution deal with Akron Biotech for HCW11-006
- HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
- HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
- Form S-1/A HCW Biologics Inc.
- HCW Biologics advances two cancer drug candidates using TGF-β/IL-15
- HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
- HCW Biologics (HCWB) files for 1.24M share offering by selling stockholders
- Form S-1 HCW Biologics Inc.
- Form 10-Q HCW Biologics Inc. For: Jun 30
Entities mentioned with HCWB
- FDA | View Related Stories »
- IPO | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S1 | View Related Stories »
- Maxim Group | View Related Stories »
- Show More...
